Marco Antonio Northland

Co-Founder & CEO | Large-Scale Battery Storage (Germany) & Orphan Drug Development | Turning Deep Tech into Real-World Impact

Berlin Metropolitan Area

About

Entrepreneur with strong international operational experience in the renewable the energy sector. Deployed over € 2 billion in infrastructure development. Successful track record in fund raising including IPO, green bond, private placement and project finance. Extensive international expansion experience in Europe, Latin American and Japan. Board member for public companies listed in Canada and Sweden.

Experience

  • Co-Founder and Chief Financial Officer at Retinagenix Holdings, Inc.
    Apr 2024 - Present · 2 yrs 4 mos

    Retinagenix is a clinical-stage biopharmaceutical company developing Zuretinol, an oral small molecule treatment for Inherited Retinal Diseases (IRDs) including RPE65, LRAT, and Usher syndrome mutations. With over 80% positive clinical response rates across seven Phase 1 studies and no adverse effects at the intended therapeutic dose, Zuretinol offers a safer, non-surgical alternative to current gene therapy approaches. Backed by FDA Orphan Drug, Fast-Track, and Rare Pediatric designations, Retinagenix is advancing a rapid path to NDA approval with potential Priority Review Voucher eligibility.

  • Founder and Geschäftsführerm at BESSMART Energies GmbH
    Oct 2023 - Present · 2 yrs 10 mos

    BESSMART Energies is a renewable energy infrastructure development company focused on greenfield development of utility scale battery storage systems in Germany

  • Etrion Corporation (17 yrs 10 mos)
    • Chief Executive Officer
      Oct 2008 - Present · 17 yrs 10 mos

      ETRION S.A. is an Independent Power Producer, with operations in Geneva Switzerland. It is developing and building large scale Solar in Japan. Lundin Group, a multinational industrial group, very active in mining and oil, is the largest shareholder in ETRION. Lundin sees the renewable sector as an strategic sector with sustainable long term growth.

    • Board Member
      Sep 2009 - Present · 16 yrs 11 mos

  • Board Member at Retinagenix Holdings, LLC
    Nov 2020 - Present · 5 yrs 9 mos

    Retinagenix is an early stage drug development company focused in rear diseases including LRAT and RPE

  • General Manager Europe at SunPower Systems
    Jun 2005 - Sep 2008 · 3 yrs 4 mos

    Responsible for establishing and leading European operations for SunPower. Primary responsibilities included forming European management team, establishing strategic direction and executing expansion strategy, managing business opportunities in key markets and leveraging U.S. resources to grow the business. Accomplishments to date include: • Secured several large scale Solar power plant projects in Spain, Italy, Germany and Portugal for a combined amount of nearly 80MWp and nearly Euro 450 Million. • Built the business to become over 70% of worldwide revenues for Systems. • Reach Q2-08 annualized run rate of $800 million in revenues. • Established extensive network with renewable energy funds, project finance banks, developers, Solar energy suppliers, distributors and industry leaders in key markets.